SSHA

Society of Sexual Health Advisers

Unite the union
  • About us
    • JOIN SSHA
    • Code of Professional Conduct
    • National Organising Professional Committee
    • National Organising Professional Committee Structure
    • Constitution and Rules
    • Council Reports
    • NPC ACCESS ONLY
  • News
  • Regions
    • London
    • North East, Yorkshire & Humberside
    • Ireland
    • Scotland
    • South West
    • East Midlands – VACANT
    • North West
    • South East
    • Wales
    • West Midlands
  • Resources
    • I Want To Be A Health Adviser
    • SSHA Manual
    • Conference Presentations
    • Competency Framework for Sexual Health Advisers
    • WeSSI: West Sussex Sexual Health Structured Interview
    • Research
    • Unite – Union
    • Publications
  • Jobs
    • Current Jobs
    • Sample Job Descriptions
  • Links
Home » Rapid ‘combination’ test fails to detect many cases of acute HIV infection

Rapid ‘combination’ test fails to detect many cases of acute HIV infection

January 12, 2012 By SSHA Leave a Comment

Roger Pebody
Published: 06 January 2012

A rapid, point-of-care test, which aims to reduce the ‘window period’ through the detection of both antibodies and p24 antigen has poor performance in a clinical setting, researchers report in an article published online ahead of print by the Journal of Infectious Diseases.

Whilst the test reliably identified people with established HIV infection, it delivered false negative results to the majority of individuals who were very recently infected with HIV.

Furthermore, this experience from Malawi echoes the findings of British researchers, published last year in Sexually Transmitted Infections.

Rapid diagnostic tests, which can be operated at the point-of-care by doctors or nurses, offer numerous advantages over conventional laboratory tests. Such devices are essential in resource-limited settings where laboratories are inaccessible or unavailable. Furthermore, as patients do not need to come back for their results on another day, far more people receive their results.

However almost all rapid tests only detect HIV antibodies, which are only detectable approximately one month after infection. In contrast, tests conducted in a laboratory may also be able to detect p24 antigen or HIV RNA, both of which are detectable earlier than this. These tests therefore shorten the ‘window period’.

Introduced in 2009, the Determine HIV-1/2 Ag/Ab Combo is the only rapid test which combines detection of antibodies and p24 antigen.

Nora Rosenberg and colleagues wished to monitor the performance of the Determine Combo test at two clinical sites in Lilongwe, Malawi. They compared the test’s results with those of other, validated tests.

Of 1009 individuals who tested, 838 were HIV-negative, 163 had established HIV-infection and 8 had acute infection (in other words, they were infected in the past few weeks). Individuals were judged to have acute infection if a laboratory test showed that they had HIV RNA but had had at least one negative result for HIV antibodies.

Among those with established HIV-infection, the test performed well. All but one individual was correctly identified, giving a sensitivity of 99.4% (95% confidence interval 96.6% – 100%).

However among the eight people with acute infection, only two were identified by the test, giving a sensitivity of 25% (95% confidence interval 3.2% – 65.1%). Moreover, these two individuals tested positive for HIV antibodies, and not for p24 antigen. While this does suggest that the antibody part of the test performs better than some other antibody tests, the p24 antigen part of the test performed poorly – but the detection of p24 antigen is key to identifying people who have recent infection.

Moreover, when the test was performed on 838 HIV-negative samples, 14 of the results for p24 antigen were false positives, further undermining the usefulness of the test in this setting.

The authors say that in this field evaluation “the sensitivity and specificity of the p24 antigen component of the test were inadequate for widespread use for detecting acute HIV infection.”

It is possible that a point-of-care test in the ‘lateral flow’ format has a much lower level of sensitivity than modern laboratory tests, which are able to detect lower concentrations of p24 antigen. An alternate possible explanation is that the test performs poorly with clade C HIV-1, the predominant subtype in Malawi.

However disappointing results have also been reported by Julie Fox of Guys’ and St Thomas’ Hospitals, London (where clade C is less common). She tested the Determine Combo test on stored samples from 36 people with HIV, each of whom had detectable p24 according to laboratory tests. Ten of them had detectable antibodies, while 26 did not (in other words, they had acute infection).

Overall, the rapid test detected p24 antigen for only half those tested, giving a sensitivity of 50% (95% confidence interval 34% – 66%).

The test failed to detect HIV infection (either via p24 antigen or antibodies) in ten of 36 cases, nine of whom had acute infection.

The researchers note that there are significant public health consequences to giving a negative HIV test result to a person whose infection is at its most infectious stage.

Specifically, Fox and colleagues recommend that combination laboratory tests are used for individuals with suspected acute infection and that health providers explain the limitations of tests to patients.

References

  • Rosenberg NE et al. Detection of Acute HIV Infection: A Field Evaluation of the Determine® HIV-1/2 Ag/Ab Combo Test. Journal of Infectious Diseases, online ahead of print, 2011. (Click here for the free abstract).
  • Fox J et al. Low rates of p24 antigen detection using a fourth-generation point of care HIV test.Sexually Transmitted Infections 87:178-179, 2011.

Taken from

  • http://www.aidsmap.com/en/Email-afriend/tpl/1412195/page/2204685/

Filed Under: Latest SSHA News Tagged With: aidsmap, antibodies, antigen, combo, hiv rna, journal of infectious diseaases, nam, national aids manual, nora rosenberg, p24, p24 antigen, poct, rapid diagnostic tests, rapid hiv test, window period

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

About SSHA

The Society of Sexual Health Advisers (SSHA) is a UK national organisation with approximately 300 members out of an estimated 350 sexual health advisers in the country. It provides an opportunity for members to meet and work towards further professional development.

Recent Posts

  • Helping People to Reduce Sexual Health Risk: A Motivational Interviewing Approach February 28, 2023

Useful Links

  • BASHH
  • HPV Action
  • NAM
  • Public Health England
  • Public Health Scotland
  • Terence Higgins Trust
  • UNITE the Union

Copyright © 2023 · SSHA - Society of Sexual Health Advisers

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT